Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 2/20 | 0.36 |
| ▸ | CTSK | P43235 | 2/20 | 0.36 |
| ▸ | KCNQ4 | P56696 | 2/20 | 0.36 |
| ▸ | KCNQ5 | Q9NR82 | 2/20 | 0.36 |
| ▸ | AAK1 | Q2M2I8 | 8/20 | 0.35 |
| ▸ | LIPE | Q05469 | 1/20 | 0.34 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | NCOA2 | Q15596 | 1/20 | 0.33 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.33 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL33527198 | 0.83 | KCNQ4 (0.36) | CTSSCTSKKCNQ4KCNQ5AAK1 | |
| SCHEMBL33525705 | 0.83 | AAK1 (0.41) | CTSSCTSKKCNQ4KCNQ5AAK1 | |
| SCHEMBL33526532 | 0.82 | KEAP1 (0.38) | CTSSCTSKKCNQ4KCNQ5AAK1 | |
| SCHEMBL29957341 | 0.82 | KDM4A (0.42) | CTSSCTSKGPR119 | |
| SCHEMBL33526461 | 0.75 | TSHR (0.41) | LMNATSHR | |
| SCHEMBL29951306 | 0.74 | KCNQ4 (0.46) | CTSSCTSKKCNQ4KCNQ5LIPE | |
| SCHEMBL16576644 | 0.74 | RIPK1 (0.35) | LIPE | |
| SCHEMBL33526561 | 0.74 | DDB1 (0.38) | KCNQ4KCNQ5AAK1 | |
| SCHEMBL33526061 | 0.74 | KCNQ4 (0.35) | KCNQ4KCNQ5AAK1LMNA | |
| SCHEMBL29952911 | 0.74 | KDM4A (0.42) | CTSSCTSKGPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | LILLY CO ELI (US) | 2026-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | GIPR, GLP1R, GPR119 | CTSS 3454/4885CTSK 3711/4885KCNQ4 2094/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.